Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,485 papers from all fields of science
Search
Sign In
Create Free Account
FAD 104
Known as:
FAD-104
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
ME 2303
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Distinct effects of clinically used anthracycline antibiotics on ras oncogene-expressed cells.
K. Tsuchiya
,
T. Kanbe
,
M. Hori
,
Y. Uehara
,
Y. Takahashi
,
T. Takeuchi
Biological and Pharmaceutical Bulletin
1993
Corpus ID: 24786126
Doxorubicin, pirarubicin, and FAD-104, but not aclarubicin or MX 2, flattened the morphology of NIH3T3 cells that had been…
Expand
1989
1989
The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104).
I. Blazsek
,
G. Mathé
,
M. Comisso
,
H. Kitasato
,
K. Umezawa
,
H. Umezawa
Biomedicine & pharmacotherapy = Biomedecine…
1989
Corpus ID: 11730119
1988
1988
Biological properties of ME2303 (FAD-104), a new anthracycline.
S. Omoto
,
S. Kondo
,
+4 authors
S. Umezawa
Drugs under experimental and clinical research
1988
Corpus ID: 43379001
ME2303 (FAD-104) is a new anthracycline antibiotic whose structure is characterized by the presence of a 2'-fluoro atom and the…
Expand
1988
1988
Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
K. Umezawa
,
T. Takeuchi
,
+6 authors
H. Umezawa
Drugs under experimental and clinical research
1988
Corpus ID: 24735997
The authors have synthesized 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) adriamycinone (FT-ADM) which exhibited strong…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE